Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis

Yu-Pei Zhuang1, Si-Qi Wang1, Zhao-Yu Pan1

  • 1Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, No. 19 Nonglinxialu, Guangzhou 510000, Guangdong Province, China.

Insights

Hepatitis B virus (HBV)-related cirrhosis increases risks of liver cancer and enlarged spleen. Alcohol-related cirrhosis more often leads to brain and liver failure complications. Different causes yield distinct cirrhosis outcomes.

Area of Science:

  • Hepatology and Gastroenterology
  • Viral Hepatitis Research
  • Alcohol-Induced Liver Disease

Background:

  • Cirrhosis is advanced liver scarring from various causes.
  • Hepatitis B virus (HBV) and alcohol abuse are leading causes of cirrhosis worldwide.
  • Understanding etiological differences in complication profiles is crucial for patient management.

Purpose of the Study:

  • To compare the specific complication rates and risks between HBV-related and alcohol-related cirrhosis.
  • To identify distinct patterns of complications based on cirrhosis etiology.

Main Methods:

  • Retrospective review of medical records for patients diagnosed with HBV-related or alcohol-related cirrhosis between January 2014 and January 2021.
  • Assessment of unadjusted complication rates and adjusted risks using statistical analysis.

Main Results:

  • HBV-related cirrhosis showed higher rates of hepatocellular carcinoma (HCC) and hypersplenism.
  • Alcohol-related cirrhosis was associated with higher rates of hepatic encephalopathy (HE) and acute-on-chronic liver failure (ACLF).
  • Adjusted analyses confirmed significantly higher risks for HCC and hypersplenism in HBV-related cirrhosis, and for HE and ACLF in alcohol-related cirrhosis.

Conclusions:

  • Cirrhosis complications vary significantly based on their underlying cause (HBV vs. alcohol).
  • HBV-related cirrhosis poses a greater risk for developing HCC and hypersplenism.
  • Alcohol-related cirrhosis is more strongly linked to HE and ACLF development.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
14
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
13
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
404
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
560
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
170